![Katie Peng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katie Peng
Directeur/Bestuurslid bij
SCHOLAR ROCK HOLDING CORPORATION
Vermogen: 2 M $ op 31-05-2026
Profiel
Katie Peng is currently Independent Director at Scholar Rock Holding Corp.
since 2024, Director at California Life Sciences Association, Independent Director at Adicet Bio, Inc. since 2023, and Chief Commercial Officer at Denali Therapeutics, Inc. since 2021.
Former roles include Senior Vice President & Head-OMNI Business Unit at Genentech, Inc., General Manager at Roche Singapore Pte Ltd. from 2012 to 2015, and General Manager at Roche Products Ltd. (Taiwan) from 2015 to 2017.
Education includes undergraduate studies at the University of California, Berkeley, and an MBA from Kelley School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2026 | 39.747 ( 0,03% ) | 2 M $ | 31-05-2026 | |
| 27-04-2026 | 368 ( 0% ) | 3 426 $ | 31-05-2026 |
Actieve functies van Katie Peng
| Bedrijven | Functie | Begin |
|---|---|---|
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 27-09-2021 |
| ADICET BIO, INC. | Directeur/Bestuurslid | 10-07-2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Bestuurslid | 15-02-2024 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Directeur/Bestuurslid | - |
Eerdere bekende functies van Katie Peng
| Bedrijven | Functie | Einde |
|---|---|---|
Roche Products Ltd. (Taiwan) | Algemeen Directeur | 01-03-2017 |
Roche Singapore Pte Ltd.
 Roche Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops new medicines and diagnostics solutions | Algemeen Directeur | 01-03-2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Opleiding van Katie Peng
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Singapore Pte Ltd.
Roche Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops new medicines and diagnostics solutions | Health Technology |
Roche Products Ltd. (Taiwan) | |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
